Both in Pharmaceuticals
Nektar Therapeutics vs Mannkind
Over the past year NKTR returned −36.5% and MNKD returned −27.7%; their daily moves had a correlation of 0.09.
NKTR −36.5% MNKD −27.7%Growth of $1, one year, split-adjusted
| Metric | NKTR | MNKD |
|---|---|---|
| Price | $38.05 | $3.96 |
| Market cap | $1.30B | $1.27B |
| Today | +0.77% | +6.17% |
| 1 month | −4.7% | +6.7% |
| 6 months | −55.3% | +11.2% |
| Year to date | −10.0% | −30.2% |
| 1 year | −36.5% | −27.7% |
| Revenue growth (YoY) | −9.3% | +42.9% |
| Gross margin | 100.0% | 73.0% |
| Net margin | −401.0% | −17.4% |
| P/E (TTM) | — | — |
| Price / sales | 23.8× | 3.2× |
| Net cash | $684.3M | -$373.9M |
| Dividend yield | — | — |
| Volatility (60d) | 69.9% | 57.6% |
| Short % of float | 21.0% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).